Evercore ISI Raises PT on Thermo Fisher Scientific (TMO) to $525 From $480

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the best strong buy healthcare stocks to buy now. On July 23, Evercore ISI raised the firm’s price target on Thermo Fisher Scientific Inc. (NYSE:TMO) to $525 from $480, keeping an Outperform rating on the shares.

Thermo Fisher Scientific’s (TMO) Dividend: Steady Payouts in a Growing Market

A workstation in a research lab stocked with laboratory products and services.

The firm told investors in a research note that while some anticipated a beat after Danaher’s print, concerns existed regarding whether FY2026 estimates were too high.

It further stated that Thermo Fisher Scientific Inc. (NYSE:TMO) adopted the right approach by giving color on FY26/FY27, and added that it expects FY 2025 to have some upside, potentially from the US and China as trends appear to be coming inline to better.

Thermo Fisher Scientific Inc. (NYSE:TMO) provides analytical instruments, reagents, equipment, software, and other services for analysis, research, diagnostics, and discovery. It operates through the Analytical Instruments, Life Sciences Solutions, Laboratory Products and Services, and Specialty Diagnostics segments.

While we acknowledge the potential of TMO to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than TMO and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.